SUNNYVALE, Calif., Oct. 24, 2013 /PRNewswire/ -- ARRAYit Corporation (OTCQB: ARYC) reports that it has received a $104,000 purchase order from the University of California for its life science instruments product line.
ARRAYit is a provider of integrated platforms, instruments, tools, kits and reagents for genomics, cancer biology, life science research on plants and animals, synthetic biology and many other exciting applications. The company's industry-leading microarray platform is installed in 4,000 research centers globally, including the University of California, as well as numerous top academic, government, biotech, pharmaceutical and diagnostic companies.
ARRAYit's technology is a favorite among researchers due to its inherent versatility, affordability and performance. The company empowers researchers to manufacture, scan and analyze microarrays prepared from cellular and synthetic DNA, RNA, proteins, peptides, carbohydrates, lipids, small molecules, tissues, whole cells and nanoparticles.
The University of California is one of the nation's most prestigious educational and research systems comprising 10 campuses, 442,000 students and employees, and an investment portfolio of retirement, endowment and cash assets of $78.5 billion. ARYC will book the sale to the University of California as revenue and earnings in the current quarter.
About ARRAYit Corporation
ARRAYit Corporation is a Sunnyvale, California-based company leading and empowering the genetic, research, pharmaceutical, and diagnostic communities through the discovery, development, and manufacture of proprietary life science technologies and consumables for disease prevention, treatment and cure. The compa
|SOURCE ARRAYit Corporation|
Copyright©2012 PR Newswire.
All rights reserved